Bronstein Ben
SEC insider (Form 3/4/5 filer). CIK 0001604458. Director at Aldeyra Therapeutics, Inc. (ALDX). 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 9, 2026. Located in LEXINGTON, MA.
Companies Bronstein Ben has filed insider reports for
- Aldeyra Therapeutics, Inc. (ALDX): Director
Bronstein Ben
CIK: 0001604458
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Aldeyra Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 9, 2026ALDX
Aldeyra Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
70K shares- - Jun 9, 2026ALDX
Aldeyra Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
5.3K shares- - Jun 9, 2026ALDX
Aldeyra Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
5K shares- - Jun 10, 2025ALDX
Aldeyra Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
62.7K shares- - Jun 10, 2025ALDX
Aldeyra Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
3.6K shares- - Jun 10, 2024ALDX
Aldeyra Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
3.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 9, 2026 | ALDX Aldeyra Therapeutics, Inc. | Award Stock Option (Right to Buy) | 70,000 | - | - | Direct |
| Jun 9, 2026 | ALDX Aldeyra Therapeutics, Inc. | Award Stock Option (Right to Buy) | 5,309 | - | - | Direct |
| Jun 9, 2026 | ALDX Aldeyra Therapeutics, Inc. | Award Stock Option (Right to Buy) | 4,977 | - | - | Direct |
| Jun 10, 2025 | ALDX Aldeyra Therapeutics, Inc. | Award Stock Option (Right to Buy) | 62,728 | - | - | Direct |
| Jun 10, 2025 | ALDX Aldeyra Therapeutics, Inc. | Award Stock Option (Right to Buy) | 3,619 | - | - | Direct |
| Jun 10, 2024 | ALDX Aldeyra Therapeutics, Inc. | Award Stock Option (Right to Buy) | 3,860 | - | - | Direct |
1-6 of 6 transactions